Lataa...
The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis
BACKGROUND: Immunoglobulin light chain (AL) amyloidosis is a rare, multi-systemic disorder characterized by two disease processes: an underlying plasma cell dyscrasia that provides the source of pathologic light chains, and the resulting organ dysfunction caused by deposition of amyloid light chain...
Tallennettuna:
| Julkaisussa: | Orphanet J Rare Dis |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523334/ https://ncbi.nlm.nih.gov/pubmed/32993758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01525-2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|